Top 20 Companies in Global Biomedical Tester Market: Statistics Report Till 2035
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
The biomedical tester market includes devices and systems which test biological samples for two purposes. First testers use biological samples to diagnose diseases and second, they track human health conditions. In 2025, the healthcare systems of the world raised their diagnostic infrastructure investments so they could detect diseases at early stages and improve their patient treatment results. The authorities established better quality requirements which testing devices must meet to maintain their testing accuracy throughout all procedures. In March 2026, the expansion of Ayushman Bharat for senior citizens resulted in increased hospital admissions which required healthcare facilities to upgrade their infrastructure and drove demand for biomedical testing and equipment validation services throughout the country.
In April 2025, CDSCO reclassified over 500 medical devices under risk-based categories, strengthening compliance requirements and significantly increasing demand for biomedical testing and certification systems. The market demand experiences significant growth because people face more infectious, chronic diseases while AI-based diagnostic systems, and point-of-care testing systems become more accessible. The market growth will continue because healthcare expenses increase and laboratory networks expand together with people using personalized medicine.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Biomedical Tester Market.
Biomedical Tester Market Size & Statistics
- The Market Size for Biomedical Tester Was Estimated to be worth USD 1.75 Billion in 2024.
- The Market is Going to Expand at a CAGR of 5.05% between 2024 and 2035.
- The Global Biomedical Tester Market Size is anticipated to reach USD 3.01 Billion by 2035.
- North America is expected to generate the largest demand during the forecast period in the Biomedical Tester Market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Biomedical Tester Market.
Market Segmentation:
Global Biomedical Tester Market Size, Share, By Test Type (Functionality Testing, Performance Testing, and Verification Testing), By End-User (Healthcare Sector, Research and Development Laboratories, Educational Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035
Regional growth and demand
Asia-Pacific is expected to grow the fastest during the forecast period in the biomedical tester market. In 2025, governments expanded healthcare access and laboratory capabilities, boosting demand for advanced biomedical testing equipment. Rising awareness of early disease diagnosis and growing investments in medical technology are key growth drivers. In 2025, Siemens Healthineers launched cost-efficient MRI and diagnostic testing systems tailored for mid-tier hospitals in India, Indonesia, and Vietnam. These systems improve accessibility to biomedical testing and enhance diagnostic efficiency across emerging APAC markets. The Asia Pacific region dominated the biomedical tester market due to rapidly expanding healthcare infrastructure, rising local manufacturing of medical devices, and increasing adoption of stringent international regulatory standards.
North America is expected to generate the largest demand during the forecast period in the biomedical tester market. In April 2025, Abbott launched the FreeStyle Libre 4 system in North America, featuring real-time glucose monitoring, AI-powered alerts, and telehealth integration, enhancing biomedical testing and chronic disease management. In October 2025, Roche Diagnostics partnered with Pfizer to develop and commercialize home-based diagnostic tests for infectious and chronic diseases, expanding biomedical testing accessibility across North America. The North America region holds the largest share in the biomedical tester market due to advanced healthcare infrastructure, stringent regulatory compliance standards (FDA), and high adoption of innovative technologies.
Ready to lead the Biomedical Tester Market ?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 trends in the Biomedical Tester Market
- Rising demand for rapid diagnostic testing
- Increasing adoption of point-of-care testing devices
- Growth in AI-integrated diagnostic solutions
- Expansion of laboratory automation systems
- Rising prevalence of chronic and infectious diseases
- Increasing demand for portable testing devices
- Advancements in biosensor technologies
- Growth in personalized medicine and precision diagnostics
- Increasing healthcare infrastructure investments
- Development of high-throughput testing systems
- Rising demand for rapid diagnostic testing
Rapid diagnostic testing enables quick disease detection, improves clinical decision-making, reduces hospital burden, and enhances patient outcomes, driving widespread adoption across healthcare systems globally.
- Increasing adoption of point-of-care testing devices
Point-of-care testing devices provide immediate results at patient locations, improving efficiency, reducing laboratory dependency, and supporting faster treatment decisions in emergency and remote healthcare settings.
- Growth in AI-integrated diagnostic solutions
AI-powered diagnostic tools enhance accuracy, automate analysis, reduce human error, and enable predictive healthcare, significantly improving disease detection rates and operational efficiency in laboratories.
- Expansion of laboratory automation systems
Laboratory automation improves workflow efficiency, minimizes manual errors, increases throughput, and supports large-scale diagnostic testing, especially in high-demand healthcare environments and research institutions globally.
- Rising prevalence of chronic and infectious diseases
Increasing cases of chronic and infectious diseases drive demand for biomedical testing devices, supporting early diagnosis, continuous monitoring, and effective disease management across global healthcare systems.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the biomedical tester market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Biomedical Tester Market.
Top 20 Companies Leading the Biomedical Tester Market
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Becton Dickinson and Company
- GE HealthCare
- Bio-Rad Laboratories
- PerkinElmer Inc.
- Agilent Technologies
- Sysmex Corporation
- Mindray Medical International
- Horiba Ltd.
- QIAGEN N.V.
- Waters Corporation
- bioMerieux
- Hologic Inc.
- Randox Laboratories
- Ortho Clinical Diagnostics
- Nova Biomedical
- Abbott Laboratories
Headquarters: Illinois, United States
Abbott Laboratories, founded in 1888 by Wallace Abbott, is headquartered in Illinois, United States. As of 2025, the company generated approximately USD 40 billion in revenue and employs over 115,000 people globally, operating in more than 160 countries. Abbott is a global leader in diagnostics and biomedical testing solutions. Its major projects include developing rapid diagnostic kits, expanding point-of-care testing devices, and investing in advanced laboratory technologies to improve global healthcare access and disease detection capabilities.
- F. Hoffmann-La Roche Ltd
Headquarters: Basel, Switzerland
F. Hoffmann-La Roche Ltd, founded in 1896 by Fritz Hoffmann-La Roche, is headquartered in Basel, Switzerland. As of 2025, the company generated over USD 65 billion in revenue and employs approximately 100,000 people globally, operating in more than 100 countries. Roche specializes in diagnostics and pharmaceuticals, including advanced biomedical testing systems. Its major projects include expanding molecular diagnostics, developing automated testing platforms, and investing in precision medicine technologies.
- Siemens Healthineers
Headquarters: Erlangen, Germany
Siemens Healthineers, established in 2017 as a spin-off from Siemens AG, is headquartered in Erlangen, Germany. As of 2025, the company generated approximately USD 23 billion in revenue and employs over 70,000 people globally. The company provides advanced biomedical testing and imaging solutions. Its major projects include AI-based diagnostics, laboratory automation systems, and expansion of integrated healthcare technologies for improved clinical outcomes.
- Danaher Corporation
Headquarters: Washington, United States
Danaher Corporation, founded in 1984, is headquartered in Washington, United States. As of 2025, the company generated over USD 31 billion in revenue and employs approximately 80,000 people globally. Danaher provides biomedical testing solutions through subsidiaries like Beckman Coulter. Its major projects include expanding diagnostic platforms, investing in life sciences technologies, and enhancing laboratory automation systems worldwide.
- Thermo Fisher Scientific
Headquarters: Waltham, United States
Thermo Fisher Scientific, founded in 2006, is headquartered in Waltham, United States. As of 2025, the company generated over USD 43 billion in revenue and employs approximately 125,000 people globally. The company is a leader in biomedical testing equipment and laboratory solutions. Its major projects include expanding diagnostic product lines, investing in high-throughput testing systems, and supporting global research and healthcare innovation.
Are you ready to discover more about the biomedical tester market?
The report provides an in-depth analysis of the leading companies operating in the global biomedical tester market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Biomedical Tester Market.
Company Profiles
- Abbott Laboratories
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Danaher Corporation
- Thermo Fisher Scientific
- Becton Dickinson and Company
- GE HealthCare
- Bio-Rad Laboratories
- PerkinElmer Inc.
- Others
Conclusion
The worldwide biomedical testing equipment industry will experience consistent expansion until 2035 because of rising needs for precise diagnostic assessments, the growing incidence of permanent, contagious health conditions, and the development of new testing technologies. The healthcare system shows major improvements because diagnostic systems, automated processes, and medical tests that function outside of traditional hospital settings work together to create better results. The market demand increases through strong regulatory systems and Ayushman Bharat - PMJAY and the developing compliance requirements from Central Drugs Standard Control Organisation. The main companies Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Siemens Healthineers drive their international business growth through continuous product development.
Our Report
https://www.sphericalinsights.com/reports/italy-seed-treatment-market
https://www.sphericalinsights.com/reports/italy-compound-feed-market
https://www.sphericalinsights.com/reports/italy-data-center-market
https://www.sphericalinsights.com/reports/italy-food-colorants-market
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?